You have 7 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

1q21.3

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Assess Outcomes of Management of Congenital Adrenal Hyperplasia

Not yet recruiting
  • Adrenal Hyperplasia, Congenital
  • Questionnaire
  • (no location specified)
Jan 27, 2022

Marginal Zone Lymphoma Trial (Mosunetuzumab + Lenalidomide, - Rituximab + Lenalidomide (28-days cycles, - Rituximab +

Not yet recruiting
  • Marginal Zone Lymphoma
  • Mosunetuzumab + Lenalidomide
  • +3 more
  • (no location specified)
Aug 16, 2023

Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11, Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11, Acute

Recruiting
  • Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11
  • +9 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 27, 2021

Healthy Trial in Nottingham (BI 685509 oral formulation prototypes, BI 685509 standard oral formulation)

Completed
  • Healthy
  • R1: Reference Product X
  • +12 more
  • Nottingham, United Kingdom
    Quotient Sciences
Dec 7, 2022

COVID-19 Trial in Gaborone (AZD 1222)

Completed
  • COVID-19
  • AZD 1222
  • Gaborone, Botswana
    Botswana Harvard Health Partnership
Feb 6, 2023

Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome, Adult Acute Basophilic Leukemia, Adult

Active, not recruiting
Has Results
  • Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome
  • +18 more
  • eltrombopag olamine
  • Cleveland, Ohio
    Case Comprehensive Cancer Center
Nov 29, 2021

Influenza, Human Trial in Gent, Wilrijk (GSK4382276A Dose level 1, GSK4382276A Dose level 2, GSK4382276A Dose level 3)

Active, not recruiting
  • Influenza, Human
  • GSK4382276A Dose level 1
  • +4 more
  • Edegem, Belgium
  • +6 more
Jan 9, 2023

Alzheimer Trial in Saint Louis ([18F]RO-948, 18F-MK6240, 18F-GTP1)

Recruiting
  • Alzheimer Disease
  • Saint Louis, Missouri
    Washington University School of Medicine
Jul 14, 2022

Influenza, Human Trial in United States (FLU-Q-PAN H7N9 Formulation 1, FLU-Q-PAN H7N9 Formulation 2, FLU-Q-PAN H7N9 Formulation

Active, not recruiting
  • Influenza, Human
  • FLU-Q-PAN H7N9 Formulation 1
  • +5 more
  • Stockbridge, Georgia
  • +6 more
Apr 18, 2022

Treatment Outcomes in Freeman-Sheldon Syndrome

Recruiting
  • Freeman-Burian Syndrome
  • +7 more
  • Guided Health History for Freeman-Burian Syndrome Questionnaire
  • +9 more
  • Fairfax, Virginia
    Office of Craig R Dufresne, MD, PC
Jul 15, 2022

Hematopoietic/Lymphoid Cancer, Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission

Completed
  • Hematopoietic/Lymphoid Cancer
  • +135 more
  • beclomethasone dipropionate
  • +4 more
  • Hackensack, New Jersey
  • +1 more
Feb 1, 2021

Acute Myeloid Leukemia, Adult Acute Megakaryoblastic Leukemia, Adult Acute Monoblastic Leukemia Trial in United States

Active, not recruiting
Has Results
  • Acute Myeloid Leukemia
  • +13 more
  • Burbank, California
  • +176 more
Mar 25, 2022

Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic

Terminated
Has Results
  • Adult Acute Megakaryoblastic Leukemia (M7)
  • +15 more
  • fludarabine phosphate
  • +4 more
  • New Brunswick, New Jersey
    Rutgers Cancer Institute of New Jersey
Aug 20, 2021

HIV-1-infection Trial in Botswana, Malawi, South Africa (3BNC117-LS-J, 10-1074-LS-J, Placebo for 3BNC117-LS-J)

Not yet recruiting
  • HIV-1-infection
  • Molepolole, Botswana
  • +8 more
Sep 8, 2023

Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22);

Completed
Has Results
  • Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
  • +10 more
  • Erlotinib Hydrochloride
  • Laboratory Biomarker Analysis
  • Houston, Texas
    M D Anderson Cancer Center
Dec 18, 2019

Anaphylactic Reaction Trial in Herston (EpiPen ®., Epinephrine (0.3mg) inhaled, Epinephrine (1.3mg))

Not yet recruiting
  • Anaphylactic Reaction
  • EpiPen ®.
  • +3 more
  • Herston, Queensland, Australia
    Q-Pharm Pty Ltd
Nov 29, 2021

Atrial Fibrillation Trial in Worldwide (OMNYPULSE Bi-Directional Catheter with TRUPULSE Generator)

Not yet recruiting
  • Atrial Fibrillation
  • OMNYPULSE Bi-Directional Catheter with TRUPULSE Generator
  • Aalst, Belgium
  • +12 more
Jul 25, 2023

Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic

Completed
Has Results
  • Adult Acute Megakaryoblastic Leukemia (M7)
  • +16 more
  • choline magnesium trisalicylate
  • +3 more
  • New Brunswick, New Jersey
    Rutgers Cancer Institute of New Jersey
Aug 20, 2021

Tumor, Ovarian Cancer Trial in Belgium, United Kingdom, United States (NKTR-102 q14d, NKTR-102 q21d)

Completed
Has Results
  • Tumor
  • Ovarian Cancer
  • NKTR-102 q14d
  • NKTR-102 q21d
  • Highland, California
  • +19 more
Jul 9, 2021

Anesthesia Trial in United Kingdom (Preliminary testing, Psychometric main study testing (Phase 5))

Recruiting
  • Anesthesia
  • Preliminary testing
  • Psychometric main study testing (Phase 5)
  • Belfast, United Kingdom
  • +5 more
Dec 19, 2022

Idiopathic Pulmonary Fibrosis Trial in Herston (PMG1015 Dose 1, PMG1015 Dose 2, PMG1015 Dose 3)

Recruiting
  • Idiopathic Pulmonary Fibrosis
  • PMG1015 Dose 1
  • +6 more
  • Herston, Queensland, Australia
    Q-Pharm Pty Ltd, Clive Berghofer Cancer Research Centre
Jul 21, 2022

Recurrent Acute Leukemia of Ambiguous Lineage, Recurrent Acute Lymphoblastic Leukemia, Recurrent Mixed Phenotype Acute Leukemia

Not yet recruiting
  • Recurrent Acute Leukemia of Ambiguous Lineage
  • +5 more
  • Biospecimen Collection
  • +12 more
  • (no location specified)
Mar 8, 2023

DLBCL, High Grade B-Cell Lymphoma w/MYC & BCL2 or BCL6 Rearrangements, High Grade B-Cell Lymphoma w/MYC, BCL2 & BCL6

Recruiting
  • Diffuse Large B-Cell Lymphoma
  • +2 more
  • Tampa, Florida
  • +1 more
Jan 12, 2022

Crohn's Disease Trial in Worldwide (Alicaforsen)

Completed
  • Crohn's Disease
  • Kortrijk, Belgium
  • +15 more
Aug 11, 2022

Acute Myeloid Leukemia, T Cell Acute Lymphoblastic Leukemia, T Cell Lymphoblastic Lymphoma Trial in Milwaukee (XmAb18968 - Dose

Recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • XmAb18968 - Dose level -1
  • +4 more
  • Milwaukee, Wisconsin
    Froedtert Hospital & the Medical College of Wisconsin
Feb 15, 2022